Tetrakis(triphenylphosphine)palladium(0), min. 98%, 1 g, glass packaging

8-Bromo-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine, 98%, 10g

1-(3-Fluoropyridin-2-yl)piperazine trihydrochloride, 1g

2-(4-Chlorophenyl)-6-nitro-1H-1,3-benzodiazole, 98+%, 100mg

3-Fluoro-2-iodoanisole, 98.0%, 25g

(S)-1-(5-Methylthiophen-2-yl)ethan-1-amine hydrochloride, 500mg

S-2-Amino-3-methyl-1,1-diphenylbutan-1-ol, 95.0%, 5g

tert-Butyl 2-amino-6-azaspiro[3.4]octane-6-carboxylate, 95.0%, 100mg

(R)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((S)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide, 97%, 10mg

4-(2,4-DIFLUOROPHENOXY)PIPERIDINE HCL, 95.0%, 250mg

6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid), 97%, 1g

Sodium 2-Mercaptoethanesulfonate>95.0%(T)25g

4,4'-(Benzo[c][1,2,5]thiadiazole-4,7-diyl)dibenzoic acid, 97%, 100mg